MLaaS and RPAaaS Platform Administration

Forecast New Requirement Updated

Agency
Solicitation expected
Estimated value
$3,000,000 to $7,000,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
511210 Software Publishers
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration is procuring administration services for a Machine Learning as a Service (MLaaS) and Robotic Process Automation as a Service (RPAaaS) platform used by the Office of Immediate Investigation (OII), Center for Drug Evaluation and Research (CDER), and Health Policy Programs (HFP). The MLaaS platform provides ready-made solutions for popular machine learning applications including intelligent forms extraction, processing, and handwriting recognition. The solicitation is estimated to release on November 1, 2026, with award anticipated on April 1, 2027.

The estimated award value ranges from $3 million to $7 million. This is a new requirement under NAICS 511210 (Software Publishers) with no set-aside applied. Inquiries should be directed to the FDA Office of Immediate Investigation vendor excellence mailbox at odtvendorexcellence@fda.hhs.gov.

Forecast text

IT Acquisition: MLaaS is used by OII,CDER, HFP. Machine Learning as a Service (MLaaS) is a set of services that offer machine learning tools that can be adopted by any organization as a part of their working needs. Machine Learning as a Service (MLaaS) is a set of services that offer machine learning tools that can be adopted by any organization as a part of their working needs. The MLaaS platforms provides ready-made solutions for the majority of popular machine learning applications including intelligent forms extraction and processing handwriting recognition.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast